Unicycive Therapeutics Inc. (UNCY)

The Moment We’ve Been Waiting For: OLC Pivotal Trial Meets Endpoints For Phosphate Control


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
June 26, 2024
Report ID: 26831
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc.
Healthcare
Biotechnology
Ticker
UNCY
Current Price
$0.398 -1.97%
Market Cap
$15.0M
Price Target
Refer to Report
Volume
2.0M
52wk Range
$0.339 - $1.818
Related Research Reports
7/11/2024

Patient Survey Data From Pivotal Trial Shows Patients Prefer OLC
Patient Survey Data From Pivotal Trial Shows Patients Prefer OLC (UNCY)
6/26/2024

The Moment We’ve Been Waiting For: OLC Pivotal Trial Meets Endpoints For Phosphate Control
The Moment We’ve Been Waiting For: OLC Pivotal Trial Meets Endpoints For Phosphate Control (UNCY)
5/29/2024

Data Presentations For OLC and UNI-494 Trials Presented
Data Presentations For OLC and UNI-494 Trials Presented (UNCY)
5/14/2024

1Q24 Reported With Pivotal OLC Data Coming In 2Q24
1Q24 Reported With Pivotal OLC Data Coming In 2Q24 (UNCY)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy